The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ

Human Molecular Genetics

Volumn 21, Issue 26, 2012, Pages 5528-5538

  Habbig, Sandra ^a   Bartram, Malte P ^a   Sägmüller, Josef G ^a   Griessmann, Anabel ^a   Franke, Mareike ^a   Müller, Roman Ulrich ^a   Schwarz, Ricarda ^a   Hoehne, Martin ^a   Bergmann, Carsten ^b,c,d   Tessmer, Claudia ^e   Reinhardt, H Christian ^a   Burst, Volker ^a   Benzing, Thomas ^a   Schermer, Bernhard ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Center for Human Genetics   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTINE; NEPHROCYSTIN PROTEIN 9; PDZ PROTEIN; TRANSCRIPTIONAL CO ACTIVATOR WITH PDZ BINDING MOTIF; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

14-3-3 PROTEINS; CELL NUCLEUS; CELL PROLIFERATION; CENTROSOME; CILIA; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; KIDNEY DISEASES, CYSTIC; LUCIFERASES; MUTATION; PHOSPHORYLATION; PLASMIDS; PROTEIN KINASES; PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 84870831806     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds408     Document Type: Article

References (35)

1. Benzing, T. and Schermer, B. (2012) Clinical spectrum and pathogenesis of nephronophthisis. Curr. Opin. Nephrol. Hypertens., 21, 272-278.
2. Hildebrandt, F., Attanasio, M. and Otto, E. (2009) Nephronophthisis: disease mechanisms of a ciliopathy. J. Am. Soc. Nephrol., 20, 23-35.
3. Sang, L., Miller, J.J., Corbit, K.C., Giles, R.H., Brauer, M.J., Otto, E.A., Baye, L.M., Wen, X., Scales, S.J., Kwong, M. et al. (2011) Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. Cell, 145, 513-528.
4. Wolf, M.T. and Hildebrandt, F. (2011) Nephronophthisis. Pediatr. Nephrol., 26, 181-194.
5. Habbig, S., Bartram, M.P., Muller, R.U., Schwarz, R., Andriopoulos, N., Chen, S., Sagmuller, J.G., Hoehne, M., Burst, V., Liebau, M.C. et al. (2011) NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J. Cell Biol., 193, 633-642.
6. Pan, D. (2007) Hippo signaling in organ size control. Genes Dev., 21, 886-897.
7. Varelas, X. and Wrana, J.L. (2012) Coordinating developmental signaling: novel roles for the Hippo pathway. Trends Cell Biol., 22, 88-96.
8. Pan, D. (2010) The hippo signaling pathway in development and cancer. Dev. Cell, 19, 491-505.
9. Benhamouche, S., Curto, M., Saotome, I., Gladden, A.B., Liu, C.H., Giovannini, M. and McClatchey, A.I. (2010) Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev., 24, 1718-1730.
10. Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M.S. and Yang, X. (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene, 30, 2181-2186.
11. Chan, S.W., Lim, C.J., Guo, K., Ng, C.P., Lee, I., Hunziker, W., Zeng, Q. and Hong, W. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res., 68, 2592-2598.
12. Chan, S.W., Lim, C.J., Loo, L.S., Chong, Y.F., Huang, C. and Hong, W. (2009) TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J. Biol. Chem., 284, 14347-14358.
13. Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A.R., Poletti, A. et al. (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell, 147, 759-772.
14. Hossain, Z., Ali, S.M., Ko, H.L., Xu, J., Ng, C.P., Guo, K., Qi, Z., Ponniah, S., Hong, W. and Hunziker, W. (2007) Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl Acad. Sci. USA, 104, 1631-1636.
15. Tian, Y., Kolb, R., Hong, J.H., Carroll, J., Li, D., You, J., Bronson, R., Yaffe, M.B., Zhou, J. and Benjamin, T. (2007) TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol. Cell. Biol., 27, 6383-6395.
16. Otto, E.A., Trapp, M.L., Schultheiss, U.T., Helou, J., Quarmby, L.M. and Hildebrandt, F. (2008) NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. J. Am. Soc. Nephrol., 19, 587-592.
17. Liu, S., Lu, W., Obara, T., Kuida, S., Lehoczky, J., Dewar, K., Drummond, I.A. and Beier, D.R. (2002) A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. Development, 129, 5839-5846.
18. Bowers, A.J. and Boylan, J.F. (2004) Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors. Gene, 328, 135-142.
19. Lin, Y.W., Yan, M.D., Shih, Y.L. and Hsieh, C.B. (2009) The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma. Eur. J. Cancer, 45, 2041-2049.
20. Luo, X., He, Q., Huang, Y. and Sheikh, M.S. (2005) Cloning and characterization of a p53 and DNA damage down-regulated gene PIQ that codes for a novel calmodulin-binding IQ motif protein and is up-regulated in gastrointestinal cancers. Cancer Res., 65, 10725-10733.
21. Zalli, D., Bayliss, R. and Fry, A.M. (2012) The Nek8 protein kinase, mutated in the human cystic kidney disease nephronophthisis, is both activated and degraded during ciliogenesis. Hum. Mol. Genet., 21, 1155-1171.
22. Kanai, F., Marignani, P.A., Sarbassova, D., Yagi, R., Hall, R.A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L.C. et al. (2000) TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J., 19, 6778-6791.
23. Lancaster, M.A. and Gleeson, J.G. (2010) Cystic kidney disease: the role of Wnt signaling. Trends Mol. Med., 16, 349-360.
24. Goetz, S.C. and Anderson, K.V. (2010) The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet., 11, 331-344.
25. Shillingford, J.M., Murcia, N.S., Larson, C.H., Low, S.H., Hedgepeth, R., Brown, N., Flask, C.A., Novick, A.C., Goldfarb, D.A., Kramer-Zucker, A. et al. (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA, 103, 5466-5471.
26. Happe, H., van der Wal, A.M., Leonhard, W.N., Kunnen, S.J., Breuning, M.H., de Heer, E. and Peters, D.J. (2011) Altered Hippo signalling in polycystic kidney disease. J. Pathol., 224, 133-142.
27. Borgal, L., Habbig, S., Hatzold, J., Liebau, M.C., Dafinger, C., Sacarea, I., Hammerschmidt, M., Benzing, T. and Schermer, B. (2012) The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate beta-catenin signaling. J. Biol. Chem., 287, 25370-25380.
28. Liebau, M.C., Hopker, K., Muller, R.U., Schmedding, I., Zank, S., Schairer, B., Fabretti, F., Hohne, M., Bartram, M.P., Dafinger, C. et al. (2011) Nephrocystin-4 regulates Pyk2-induced tyrosine phosphorylation of nephrocystin-1 to control targeting to monocilia. J. Biol. Chem., 286, 14237-14245.
29. Shiba, D., Manning, D.K., Koga, H., Beier, D.R. and Yokoyama, T. (2010) Inv acts as a molecular anchor for Nphp3 and Nek8 in the proximal segment of primary cilia. Cytoskeleton (Hoboken), 67, 112-119.
30. Fukui, H., Shiba, D., Asakawa, K., Kawakami, K. and Yokoyama, T. (2012) The ciliary protein Nek8/Nphp9 acts downstream of Inv/Nphp2 during pronephros morphogenesis and left-right establishment in zebrafish. FEBS Lett, 586, 2273-2279.
31. Hilton, L.K., White, M.C. and Quarmby, L.M. (2009) The NIMA-related kinase NEK1 cycles through the nucleus. Biochem. Biophys. Res. Commun., 389, 52-56.
32. Debnath, J., Walker, S.J. and Brugge, J.S. (2003) Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. J. Cell Biol., 163, 315-326.
33. Dafinger, C., Liebau, M.C., Elsayed, S.M., Hellenbroich, Y., Boltshauser, E., Korenke, G.C., Fabretti, F., Janecke, A.R., Ebermann, I., Nurnberg, G. et al. (2011) Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and microtubule dynamics. J. Clin. Invest., 121, 2662-2667.
34. Schermer, B., Hopker, K., Omran, H., Ghenoiu, C., Fliegauf, M., Fekete, A., Horvath, J., Kottgen, M., Hackl, M., Zschiedrich, S. et al. (2005) Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin and targeting to cilia. EMBO J., 24, 4415-4424.
35. Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495-497.